2015
DOI: 10.1002/14651858.cd008553.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Prophylactic lidocaine for myocardial infarction

Abstract: Analysis 1.9. Comparison 1: Lidocaine vs placebo or no intervention, Outcome 9: All-cause mortality (subgroup analysis according to non-suspected trials with industry bias compared with suspected trials with industry bias

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
12
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(13 citation statements)
references
References 129 publications
1
12
0
Order By: Relevance
“…2a and b). The dynamic pattern of these ST segments supports the diagnosis of MI 41, 47 . Intraoperative ventricular arrhythmias requiring intracardiac defibrillation were observed in 8 of 27 animals.…”
Section: Resultssupporting
confidence: 59%
“…2a and b). The dynamic pattern of these ST segments supports the diagnosis of MI 41, 47 . Intraoperative ventricular arrhythmias requiring intracardiac defibrillation were observed in 8 of 27 animals.…”
Section: Resultssupporting
confidence: 59%
“…Lidocaine has been found to not diminish the antiplatelet effects of ticagrelor, making it a promising non-opioid pain relief option. Furthermore, the use of lidocaine in patients with STEMI did not uncover an increased likelihood of bradyarrhythmia, tachyarrhythmia or neurotoxicity ( 35 ). A clinical study comparing intravenous acetaminophen and fentanyl for pain relief in patients with STEMI found no difference between the two.…”
Section: Discussionmentioning
confidence: 99%
“…As sudden cardiac death is often precipitated by a brief monomorphic tachycardia that degenerates into VF (Milner et al., ; Panidis & Morganroth, ), a failure to flatten the dynamic restitution slope may limit the therapeutic potential of lidocaine and mexiletine in preventing a fatal arrhythmia. In this context, it is worth mentioning that although class Ib agents are generally regarded as safe antiarrhythmics (Frommeyer & Eckardt, ), they nevertheless reportedly failed to improve mortality in patients with acute myocardial infarction in recent clinical trials (Marti‐Carvajal, Simancas‐Racines, Anand, & Bangdiwala, ); hence the routine use of prophylactic lidocaine for the purpose of preventing VF in this setting is not currently recommended.…”
Section: Discussionmentioning
confidence: 99%